NASDAQ:AGLE - Aeglea Bio Therapeutics Earnings Date, Estimates & History

-0.37 (-4.17 %)
(As of 09/16/2019 04:06 AM ET)
Today's Range
Now: $8.50
50-Day Range
MA: $8.06
52-Week Range
Now: $8.50
Volume93,574 shs
Average Volume55,111 shs
Market Capitalization$245.57 million
P/E RatioN/A
Dividend YieldN/A


Aeglea Bio Therapeutics (NASDAQ:AGLE) Earnings History and Estimates Chart

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Aeglea Bio Therapeutics (NASDAQ:AGLE) Earnings Estimates

Current Year EPS Consensus Estimate: $-2.28 EPS
Next Year EPS Consensus Estimate: $-2.43 EPS

Aeglea Bio Therapeutics (NASDAQ AGLE) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/6/2019Q2 2019($0.4820)($0.55)($0.55)N/A
8/9/2018Q2 2018($0.3640)($0.46)($0.46)$2.38 millionN/A
5/8/2018Q1 2018($0.4430)($0.49)($0.49)$1.51 millionN/A
3/13/2018Q4 2017($0.38)($0.38)$1.48 millionN/A
11/7/2017Q3 2017($0.55)($0.48)($0.48)$1.26 millionN/A
8/9/2017Q2 2017($0.59)($0.47)($0.47)$1.48 millionN/A
5/9/20173/31/2017($0.47)($0.47)($0.47)$0.98 millionN/A
3/23/2017Q4 2016($0.41)($0.41)$1.25 millionN/A
11/9/20169/30/2016($0.54)($0.47)($0.47)$1.15 millionN/A
8/9/2016Q2 2016($0.43)($0.46)($0.46)$1.37 millionN/A
5/19/2016Q1 2016($0.42)($7.10)($7.10)$0.86 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/16/2019 by Staff

Featured Article: Analyst Ratings Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel